Open a new window in the world of circulating microRNAs by merging ChemiRNA Tech with a Luminex platform†
Metadatos
Mostrar el registro completo del ítemAutor
Marín Romero, Antonio; Tabraue-Chávez, Mavys; W. Dear, James; Diaz Mochon, Juan José; Pernagallo, SalvatoreEditorial
Royal Society of Chemistry
Fecha
2022-10-05Referencia bibliográfica
Marín Moreno, A. et. al. Sens. Diagn., 2022, 1, 1243. [https://doi.org/10.1039/D2SD00111J]
Patrocinador
DESTINA Genomica; Estars 2 programme under the grant number 114589Resumen
microRNAs are small noncoding RNA molecules showing huge promise as biomarkers and diagnostic tools
for illnesses, as significant changes in their expression occur in response to pathological states. However,
multiplex detection of microRNAs represents a major challenge towards the use of microRNA signatures.
Hence, our group has tackled this need by developing an accurate and PCR-free approach to detect
multiple microRNAs in serum samples. ChemiRNA Tech has been refined to be merged with a Luminex
xMAP system. The combination of these two technologies has created a unique bead-based multiplex assay
capable of simultaneously measuring miR-122-5p, miR-451a-5p and miR-193a-5p in only 10 μL of serum.
This novel multiplex assay for the direct quantitative measurement of circulating microRNA signatures offers
benefits over gold standard singleplex assay techniques in terms of cost, time savings and ease of use.





